I walked into my ENT's office last year and he was watching his screen while waiting for me. We exchanged a few comments about our stocks and then got down to business. :)
I am on Scottrade and there is no short attack on as far as I can see. Last price on T&S is $5.21 - yesterday's close.
Fantastic! Can you post a pic on twitter and tweet that you are a new user? If you include #afrezza and @afrezzauser in your post a lot of others will pick it up and follow you.
I don't think #1 is too likely because user feedback had been readily available at the time the piece was written, and I find it extremely hard to believe that Goldman would really make a call based on a few weeks of script data. I think 2 and 3 are much more feasible. As I think about the whole downgrade, it is interesting that the downgrade was made by a first time writer who happened to have worked at Pfizer (wink wink). I believe that Olson could have been given the job of writing the analysis to lend an air of credibility to what to me was obviously a weak analysis in order to scare some retail longs send a dog whistle to shorts. As I believe I said before, if any analyst presented an analysis like that to any of my former consulting clients they would have been laughed out of the room. JMHO.
Excellent! This is the kind of thinking that I like. And as an Appl owner, I really like it. I have heard talk of an app for Apple that does blood glucose monitoring. Not sure if it exists yet or not.
I knew there was a reason I had you blocked. Such a short term thinker with no vision. Adios again.
Here is the latest Tweet from AmyTenderich of DiabetesMine (nearly 4000 followers):
"Still amazed at how well I'm doing on #Afrezza ! Post-breakfast 1hr spin class level at ~80 #bgnow whole time w/pump suspended @afrezzauser"
When I see trusted individuals like Amy make this kind of comment, I believe that a lot more conversions to Afrezza are soon to follow.
Oh really. Here's an example of a workshop at the meeting. I referred to it as a breakout session but this is what I meant. A professional promotional video would be quite nice for particular session:
Cases Studies: Improving Diabetes Outcomes with New Medications
Jennifer B Marks, MD David L. Joffe, BSPharm, CDE
It's hard to say. Users said they were contacted by a promotional firm which is different from an advertising firm. A promo firm would make videos for events like this as well as for internal sales meetings, sales presentations to accounts, etc. These videos are usually not of TV advertising quality. That said, I would love to wrong if they are for TV.
You clearly haven't been following users on Twitter. They have visual proof of their experience with Afrezza via their CGMs. It will not be opinion, it will be personal experience backed by data of which they have proof. That is science combined with real life experience - I completely disagree with you that their experience is not relevant and unscientific. I guess we'll see who's right.
I'm not talking about a booth for Afrezza users to show a video. A promotional firm has contacted several users on Twitter asking them if they would be willing to appear in a promotional video. Check out Lureen's posts. A few others mentioned it as well. I have been to these kinds of things before though not the diabetes one. There are usually speakers at the event followed by break out sessions for those interested in certain subject matter. I could easily see a video being used in those venues.